Literature DB >> 24704162

Extensively self-renewing erythroblasts derived from transgenic β-yac mice is a novel model system for studying globin switching and erythroid maturation.

Michael Getman1, Samantha J England2, Jeffery Malik1, Kenneth Peterson3, James Palis1, Laurie A Steiner4.   

Abstract

Globin gene regulation occurs in the context of a maturing erythroid cell, which is undergoing significant changes in chromatin structure and gene expression. There are few model systems available that facilitate studies of globin gene regulation in the context of erythroid maturation. Extensively self-renewing erythroblasts (ESREs) are a nontransformed model of erythroid maturation derived from murine fetal liver or yolk sac. Imaging flow cytometry and RNA-seq studies demonstrate that ESREs functionally and molecularly model erythroid maturation. To address the need for a model system that also recapitulates human globin switching, ESREs were derived from mice transgenic for the complete human β-globin locus (β-yac ESREs). β-yac ESREs express β-globin from the transgenic human locus, with minimal γ-globin expression. When treated with hydroxyurea or inhibitors to histone deacetylases, DNA methyltransferases, or the histone demethylase lysine specific demethylase 1 (LSD1), β-Yac ESREs significantly increase their γ-globin expression, demonstrating their utility for studying agents that influence maturational globin switching. β-yac ESREs were further used to characterize the secondary effects of LSD1 inhibition on erythroid maturation, with inhibition of LSD1 resulting in altered cell and nuclear size, prolonged Kit expression, and decreased rates of enucleation consistent with impaired maturation. Taken together, these studies demonstrate that β-yac ESREs have significant utility for identifying modulators of maturational globin switching as well as for studying the broader role of those modulators in erythroid maturation.
Copyright © 2014 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24704162      PMCID: PMC6176860          DOI: 10.1016/j.exphem.2014.03.006

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  40 in total

1.  Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.

Authors:  Samantha J England; Kathleen E McGrath; Jenna M Frame; James Palis
Journal:  Blood       Date:  2010-12-02       Impact factor: 22.113

Review 2.  Induction of hemoglobin F synthesis in patients with beta thalassemia.

Authors:  T J Ley; A W Nienhuis
Journal:  Annu Rev Med       Date:  1985       Impact factor: 13.739

3.  Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4.

Authors:  Osamu Tanabe; David McPhee; Shoko Kobayashi; Yannan Shen; William Brandt; Xia Jiang; Andrew D Campbell; Yei-Tsung Chen; Chawn shang Chang; Masayuki Yamamoto; Keiji Tanimoto; James Douglas Engel
Journal:  EMBO J       Date:  2007-04-12       Impact factor: 11.598

Review 4.  Formation of mammalian erythrocytes: chromatin condensation and enucleation.

Authors:  Peng Ji; Maki Murata-Hori; Harvey F Lodish
Journal:  Trends Cell Biol       Date:  2011-05-17       Impact factor: 20.808

5.  DNA methylation and globin gene expression in patients treated with 5-azacytidine.

Authors:  T J Ley; N P Anagnou; C T Noguchi; A N Schechter; J DeSimone; P Heller; A W Nienhuis
Journal:  Prog Clin Biol Res       Date:  1983

6.  Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia.

Authors:  Antonello Mai; Katija Jelicic; Dante Rotili; Antonella Di Noia; Elena Alfani; Sergio Valente; Lucia Altucci; Angela Nebbioso; Silvio Massa; Renzo Galanello; Gerald Brosch; Anna Rita Migliaccio; Giovanni Migliaccio
Journal:  Mol Pharmacol       Date:  2007-07-31       Impact factor: 4.436

7.  Use of yeast artificial chromosomes (YACs) in studies of mammalian development: production of beta-globin locus YAC mice carrying human globin developmental mutants.

Authors:  K R Peterson; Q L Li; C H Clegg; T Furukawa; P A Navas; E J Norton; T G Kimbrough; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 8.  beta-YAC transgenic mice for studying LCR function.

Authors:  K R Peterson; P A Navas; G Stamatoyannopoulos
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

9.  A dual reporter mouse model of the human β-globin locus: applications and limitations.

Authors:  Petros Papadopoulos; Laura Gutiérrez; Reinier van der Linden; John Kong-A-San; Alex Maas; Dubravka Drabek; George P Patrinos; Sjaak Philipsen; Frank Grosveld
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Mi2β is required for γ-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β-YAC transgenic mice.

Authors:  Flávia C Costa; Halyna Fedosyuk; Allen M Chazelle; Renee Y Neades; Kenneth R Peterson
Journal:  PLoS Genet       Date:  2012-12-20       Impact factor: 5.917

View more
  5 in total

1.  Histone methyltransferase Setd8 represses Gata2 expression and regulates erythroid maturation.

Authors:  Jeffrey Malik; Michael Getman; Laurie A Steiner
Journal:  Mol Cell Biol       Date:  2015-04-06       Impact factor: 4.272

Review 2.  Imaging flow cytometry for the study of erythroid cell biology and pathology.

Authors:  Leigh Samsel; J Philip McCoy
Journal:  J Immunol Methods       Date:  2015-04-07       Impact factor: 2.303

3.  Adult-repopulating lymphoid potential of yolk sac blood vessels is not confined to arterial endothelial cells.

Authors:  Chaojie Wang; Yandong Gong; Anbang Wei; Tao Huang; Siyuan Hou; Junjie Du; Zongcheng Li; Junliang Wang; Bing Liu; Yu Lan
Journal:  Sci China Life Sci       Date:  2021-06-23       Impact factor: 6.038

Review 4.  Recent trends in the gene therapy of β-thalassemia.

Authors:  Alessia Finotti; Laura Breda; Carsten W Lederer; Nicoletta Bianchi; Cristina Zuccato; Marina Kleanthous; Stefano Rivella; Roberto Gambari
Journal:  J Blood Med       Date:  2015-02-19

5.  Early Development of Definitive Erythroblasts from Human Pluripotent Stem Cells Defined by Expression of Glycophorin A/CD235a, CD34, and CD36.

Authors:  Bin Mao; Shu Huang; Xulin Lu; Wencui Sun; Ya Zhou; Xu Pan; Jinfeng Yu; Mowen Lai; Bo Chen; Qiongxiu Zhou; Song Mao; Guohui Bian; Jiaxi Zhou; Tatsutoshi Nakahata; Feng Ma
Journal:  Stem Cell Reports       Date:  2016-10-06       Impact factor: 7.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.